In the context of ovarian cancer, AUC analysis has shown that CRP/Alb was superior to other inflammation-based prognostic scores in terms of predictive accuracy, which is consistent with several previous studies in hepatocellular carcinoma [20], gastric cancer [21] and esophageal squamous cell carcinoma [22, 23]. The gene discussed is CRP; the disease is ovarian cancer.